Quote | Nuvalent Inc. (NASDAQ:NUVL)
Last: | $70.88 |
---|---|
Change Percent: | -1.56% |
Open: | $73.77 |
Close: | $70.88 |
High: | $73.77 |
Low: | $70.6 |
Volume: | 348,595 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | Nuvalent Inc. (NASDAQ:NUVL)
2024-05-16 16:18:34 ET More on Nuvalent Nuvalent: Pivotal NSCLC Programs Progressing With Additional Data In 2024 Jefferies starts Nuvalent at buy, cites lung cancer drug candidates Nuvalent lung cancer candidate gets FDA breakthrough therapy status Seeking A...
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 PR Newswire CAMBRIDGE, Mass. , May 16, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therap...
Message Board Posts | Nuvalent Inc. (NASDAQ:NUVL)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Nuvalent Inc. Company Name:
NUVL Stock Symbol:
NASDAQ Market:
Nuvalent Receives U.S. FDA Breakthrough Therapy Designation for NVL-655 PR Newswire CAMBRIDGE, Mass. , May 16, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therap...
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results PR Newswire Updates from the ongoing Phase 1/2 ARROS-1 and ALKOVE-1 clinical trials expected at a medical meeting in the second half of 2024 S...
2024-04-13 13:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...